Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Healthcare Providers Must Combine Zero Trust Architecture and Threat Modeling to Address Cybersecurity Challenges

Healthcare organizations face escalating cybersecurity threats that require a combined approach of zero trust architecture and threat modeling to effectively protect patient data. Layering continuous verification protocols with predictive security assessments enables providers to anticipate and mitigate risks before they materialize. This integrated strategy is increasingly essential as healthcare systems manage complex, interconnected digital environments.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By Mike Isbitski · FdaHealthcare CybersecurityHealthcare TechnologiesMike Isbitski
Share

Key takeaways

01

Zero trust architecture eliminates implicit trust and requires continuous verification of all users and devices accessing healthcare systems.

02

Threat modeling enables healthcare organizations to proactively identify vulnerabilities and prioritize security resources against likely attack vectors.

03

Combining zero trust with threat modeling creates a more resilient, layered defense for protecting sensitive patient data.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In today’s increasingly digital world, the healthcare sector faces significant cybersecurity challenges, necessitating urgent and sophisticated responses. The recent draft guidance issued by the FDA on cybersecurity for medical devices highlights a critical juncture for the industry: the need to implement and scale best practices in cybersecurity is more pressing than ever. As healthcare continues to integrate advanced technology, from medtech devices to comprehensive electronic health records, the potential for security breaches grows, underscoring the stakes involved in protecting sensitive health information.

What are the most effective strategies for healthcare organizations to not only implement but also scale and automate these cybersecurity best practices?

Mike Isbitski, the Director of Cybersecurity Strategy at Sysdig, shares his take on the imperative role of implementing and scaling cybersecurity best practices in the healthcare industry on an episode of Expert’s Talk. Isbitski emphasizes the importance of adopting a zero-trust architecture, threat modeling and enhancing supply chain security through comprehensive management of software and hardware components and more to tackle cybersecurity challenges in healthcare.

Isbitski emphasizes the importance of adopting a zero-trust architecture, threat modeling and enhancing supply chain security through comprehensive management of software and hardware components and more to tackle cybersecurity challenges in healthcare.

Here are the key takeaways from Isbitski’s analysis:

  • Zero Trust Architecture: Emphasizing the shift towards a zero trust framework, which is crucial for protecting against internal and external breaches.
  • Supply Chain Risks: Highlighting the importance of understanding and securing the supply chain, particularly with the use of Software and Hardware Bills of Materials (SBOMs and HBOMs) to manage risks effectively.
  • Regulatory Guidance: Discussing the new FDA cybersecurity guidelines, which aim to tailor cybersecurity measures specifically for the healthcare and medtech sectors.
  • Automation and Scalability: Addressing the critical need for cybersecurity strategies to be scalable and automated to handle the increasing volume and sophistication of threats.
  • Threat Modeling: Advocating for a proactive approach in threat modeling to anticipate and mitigate potential security threats before they materialize.
Video TranscriptExpand ↓

Yeah. I'd say it sometimes gets lumped under zero trust as an umbrella or maybe zero trust architecture. But, yeah, it's it's absolutely accurate, Doctor. Robin. Yeah, and the supply chain risk is definitely a big component of national cybersecurity strategy. Then technologically, that starts to get into bills of materials. You know? SBOM is usually one of the more well known, but, there's also hardware bombs. Right? Because specifically in this sector, right, with medtech and, you know, connected devices, that it's gonna look substantially different than just the software piece. So So now you have multiple bombs, and then you have to rationalize that. But are your providers even creating and maintaining them and then furnishing them to you? That's that's a big gap. Right? We have a lot of work to do there. I do like that the cybersecurity strategy called it out. The other thing I that I should call attention to is, like, the FDA. FDA just, issued cybersecurity guidance, draft guidance, on this topic. Right? So very specific to these industries. Right? It's, the technology is very much the same. Right? We're talking about segmentation, microsegmentation, access control, detection and response capabilities, you know, bills of materials, managing your suppliers. But how do you put that in the language of the specific health care industry or when you're dealing with, medical devices? So that draft guidance exists. You know, hopefully, that moves along very quickly, and then organizations start to adopt it. But, yeah, fundamentally, like, those security principles are there. We just we really need to start doing it. Right? We and then for myself, you know, kind of in my career, how I've approached the problem is, you know, if I get involved in a discussion on how I'm gonna solve a problem, it's kind of, well, how are we gonna scale this, and then how are we gonna automate it? Right? Because if you start pulling out a piece of paper and then you're expecting to track that, right, and this is going back twenty five years, I'm like, that's never gonna work. Right? And now, you know, twenty twenty four, it's like, there's no way. Like, so if you're doing that, you've already lost. So we we need to be thinking, you know, ten steps ahead, and then how are people gonna compromise this data? Right? You might say that's threat modeling and that that would be another concept within the cybersecurity strategies, but you you have to kinda retrain your brain to think that way.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MI
Mike Isbitski

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MI
Mike Isbitski

Director of Cybersecurity Strategy at Sysdig

Mike Isbitski is a cybersecurity strategist with deep expertise in zero trust architecture, cloud-native security, and application security. He has held advisory and strategy roles at organizations including Sysdig and TechTarget, focusing on helping enterprises navigate modern security challenges. Isbitski is a frequent speaker and contributor on topics including DevSecOps, API security, and threat modeling.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512